menu
    • menu

    Company profile for NanoAlvand

    Nanoalvand-PSE
    News
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy

    17 Apr 2025

    // PRESS RELEASE

    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    Global ChemShow

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/excipient-market-overview-evonik-launches-high-purity-excipients-india-mandates-disclosures-from-march-2026

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    PharmaCompass

    NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Related CompaniesRelated Companies

    About

    NanoAlvand©, founded in 2011, is a premier pharmaceutical company dedicated to producing high-quality medications with a primary focus on oncology, rheumatology & neurology. We offer liquid, solid, and semi-solids-designed to meet diverse therapeutic needs & strong export ties across the Middle East, EAEU, and ASEAN, we are actively expanding into new international markets. Committed to quality, compliance & continuous innovation, we collaborate with top global suppliers and pursue strategic partnerships through joint ventures and technology transfer. We welcome suppliers, manufacturers, & distributors to join us-Our Hope Shapes The Future.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NanoAlvandIran Flag
    Country
    Country
    Iran
    Address
    Address
    Unit 52, 5th floor, No. 485, Between 63 St. & 65 St.,Asad Abadi St., Yousef A...
    Telephone
    Telephone
    +98 2191077339
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nanoalvand.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nano-alvand-pharmaceutical-co-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-83967.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-90057.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy

    17 Apr 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/201-adriax-release

    PRESS RELEASE
    17 Apr 2025
    Share Share
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/197-forbes

    PRESS RELEASE
    09 Dec 2024
    Share Share
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/191-ifoxa-release

    PRESS RELEASE
    30 Nov 2024
    Share Share
    Introducing Vicrista® – A New Era in Pediatric Oncology
    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/192-vicrista-release

    PRESS RELEASE
    03 Nov 2024
    Share Share
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters

    22 Oct 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/190-top-exporters

    PRESS RELEASE
    22 Oct 2024
    Share Share
    Endoxyna®; A crucial medication with a novel solution formulation
    Endoxyna®; A crucial medication with a novel solution formulation

    29 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    29 Jun 2024
    Share Share

    Services

    Discover the service capabilities from this company

    Packaging

    Discover their expertise for : Packaging

    Analytical

    Discover their expertise for : Analytical

    Drug Product Manufacturing

    Discover their expertise for : Drug Product Manufacturing

    Sales, Marketing, Registration

    Discover their expertise for : Sales, Marketing, Registration

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search